SLOANE WILSON: Open Payments
NPI 1871145607 · FORT COLLINS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$455 in 19 payments from 7 companies in 2025. Trend: 2023 $229 · 2024 $139 · 2025 $455
Food & beverage: $455
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 10 | $275 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Neurocrine BioSciences, Inc. | 2 | $34 |
| Braeburn Inc. | 1 | $26 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
Products named: ARISTADA, VIVITROL, COBENFY, UZEDY, INGREZZA, BRIXADI, INVEGA SUSTENNA, ABILIFY ASIMTUFII.
Industry payments across CO — which companies pay providers there.
